Alces Flight Limited
13.6.2024 10:01:37 CEST | ACCESS Newswire | Press release
YORK, ENGLAND / ACCESSWIRE / June 13, 2024 / The University of York has selected Alces Flight to enhance the operation of its High-Performance Computing (HPC) infrastructure while significantly reducing its carbon footprint. This collaboration aims to upgrade the capabilities of the Viking 2 cluster, which is essential for York's research in diverse fields such as Crystal Structure Prediction and Person-specific Automatic Speaker Recognition.
To view this piece of content from cdn.nwe.io, please give your consent at the top of this page.A woman with lab gear adjusts a microscope which is pointed at a petri dish.
Viking 2, the University's HPC cluster, currently supports over 3,500 applications and achieves 75% utilisation across more than 880 users. This state-of-the-art infrastructure is pivotal in advancing research, especially in structural biology through the use of revolutionary cryo-electron microscopy (cryo-EM). Cryo-EM enables scientists to study the architecture of cells, viruses, and protein assemblies at molecular resolution, leading to groundbreaking discoveries.
Dr. Emma Barnes, Head of Research and Faculty IT at the University of York, stated: "This collaboration enables our experts in engineering, biological sciences, and artificial intelligence to process data and perform complex tasks at high speeds. It also ensures that our research IT infrastructure is both sustainable and accessible. The advanced capabilities of Viking 2 have already propelled projects like our cutting-edge work in cryo-EM, which is revealing new insights into molecular structures."
The Viking 2 cluster is located in Sweden and hosted in partnership with EcoDataCenter, which specialises in data centres that prioritise renewable energy and heat capture and reuse. This aligns with the University's commitment to sustainability and reducing its carbon emissions. By leveraging EcoDataCenter's environmentally friendly facilities, the University of York aims to meet its goal of achieving net-zero emissions on campus by 2050.
Michael Rudgyard, CEO of Alces Flight, stated: "Our long-standing relationship with the University of York allows us to support their commitment to achieving net-zero emissions. We are excited to be a part of their journey towards more sustainable and efficient research computing. The Viking 2 project is a testament to what can be achieved when cutting-edge technology meets a strong commitment to sustainability."
Cristin Merrit, CMO of Alces Flight, added: "The focus on sustainability in High-Performance Computing is critical for the future of advanced research and technologies. We are thrilled to support the University of York's pioneering projects, including the transformative Viking 2 initiative. Our collaboration with EcoDataCenter ensures that we can deliver powerful computing resources while minimising environmental impact."
Contact Information
Cristin Merritt
CMO
cristin.merritt@alces-flight.com
01869 249065
SOURCE: Alces Flight Ltd
To view this piece of content from stats.nwe.io, please give your consent at the top of this page.View the original press release on newswire.com.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
UK-Based Vesalic Limited Emerges from Stealth with Landmark Discovery of Potential Non-CNS Driver of Motor Neuron Diseases, including ALS, and Breakthrough Therapeutic and Diagnostic Opportunities9.2.2026 06:00:00 CET | Press release
This groundbreaking discovery has revealed a systemic metabolic dysfunction that creates a toxic exosome cargo in ALS patients, which is carried to the CNS, where it binds to and damages neurons Vesalic is pioneering a novel therapeutic to intercept and neutralise these toxins, potentially slowing or halting progression of monogenic and sporadic forms of ALS In addition, Vesalic has discovered a disease-specific alteration of the lipid composition in the membranes of exosomes circulating in the blood, and has developed a highly accurate biomarker-based technology to detect both monogenic and sporadic ALS Based on its novel biomarker discoveries, Vesalic is also applying its biomarker technology for other neurodegenerative diseases, including Alzheimer's and Parkinson's LONDON, UK / ACCESS Newswire / February 9, 2026 / Vesalic Limited, an early-stage neurodegenerative disease-focused biotech company, today emerged from stealth with the landmark discovery of a systemic process - largely
Innodata to Report Fourth Quarter and Fiscal Year 2025 Results5.2.2026 14:30:00 CET | Press release
NEW YORK, NY / ACCESS Newswire / February 5, 2026 / INNODATA INC. (Nasdaq:INOD) today announced that it will report Fourth Quarter and Fiscal Year 2025 results after the market closes on Thursday, February 26, 2026. A news release will be available in both the News and Investor Relations sections of the Innodata website, www.innodata.com. Innodata has scheduled an investor conference call for 5:00 PM Eastern time on that same day. The call-in numbers for the conference call are: (+1) 800 549 8228 North America (+44) 800 279 7040 United Kingdom (+1) 289 819 1520 International Participant Access Code 27117 # Replay dial-In (+1) 888 660 6264 North America (+1) 289 819 1325 International: Replay Passcode 27117 # Investors are also invited to access a live Webcast of the conference call at the Investor Relations section of Innodata's website at https://investor.innodata.com/events-and-presentations/. Please note that the Webcast feature will be in listen-only mode. Call-in replay will be av
Datavault AI Chief Executive Officer and President Issues Letter to Stockholders Highlighting 2025 Accomplishments and Outlook for 20265.2.2026 12:00:00 CET | Press release
Datavault AI signed $49M of Tokenization and Technology Licensing agreements in Q4'25 that impact FY2025 and FY2026 Revenue. Revenue: Datavault AI expects at least $30 million in revenue for FY2025, compared to $2.7 million in FY2024. This represents an increase of more than 1,000% growth in our revenue over 2024. The Company continues to expand to drive substantial near- and long-term accretion to our cash flows and earnings with a revenue target for 2026 of at least $200 million. PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / February 5, 2026 / Datavault AI Inc. (NASDAQ:DVLT) ("Datavault AI" or the "Company"), a leader in data monetization, credentialing, digital engagement and real-world asset (RWA) tokenization technologies, today issued a letter from Nathaniel Bradley, its Chief Executive Officer, to its stockholders highlighting the Company's accomplishments in 2025 and its outlook for 2026. A MESSAGE FROM OUR CHIEF EXECUTIVE OFFICER Dear Datavault AI Stockholders, I would like t
AGFA HealthCare Named Best in KLAS(R) 2026 Across Three Enterprise Imaging Segments in the United States4.2.2026 15:45:00 CET | Press release
Industry recognition for the third consecutive year reinforces AGFA HealthCare's clinician-first commitment, and leadership in empowering connected, high-performance imaging environments MORTSEL, BE / ACCESS Newswire / February 4, 2026 / AGFA HealthCare today announced that it has been named Best in KLAS® 2026 across three Enterprise Imaging segments in the United States, with two awards earned for the second consecutive year, underscoring the company's continued leadership in delivering clinician-first imaging solutions trusted by healthcare organizations worldwide. The recognition comes as KLAS Research marks its 30th anniversary, celebrating three decades of amplifying the voice of healthcare providers through independent, data-driven insights. AGFA HealthCare's Best in KLAS distinctions reflect strong customer validation of its Enterprise Imaging platform - designed to empower clinicians to stay in their flow, reduce complexity across imaging workflows, and enable confident clinica
Preservica Redefines Digital Preservation with Powerful Built-In AI Tools4.2.2026 15:00:00 CET | Press release
OXFORD, UK and BOSTON, MA / ACCESS Newswire / February 4, 2026 / Preservica, the leader in AI-powered Active Digital Preservation™, today announced the rollout of integrated, human-centered AI tools and flexible AI Credits across its product editions. These new features make AI assistance a seamless part of everyday archival workflows, empowering organizations of all sizes to safely adopt AI and scale its use as their needs grow. "With the sheer volume of digital content in backlogs and being created daily, using AI to assist in archival tasks has now become essential" says Stuart Reed, Chief Product Officer at Preservica "Seamlessly integrating human-centered AI tools across our product editions turns AI for Digital Preservation into reality - enabling organizations of all sizes to accelerate routine work, cut backlogs and enhance discovery." Developed in collaboration with Preservica's user community and refined through the company's highly rated AI Workshop series, these embedded to
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
